These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 7830567)

  • 1. The RTX haemolysins ApxI and ApxII are major virulence factors of the swine pathogen Actinobacillus pleuropneumoniae: evidence from mutational analysis.
    Tascón RI; Vázquez-Boland JA; Gutiérrez-Martín CB; Rodríguez-Barbosa I; Rodríguez-Ferri EF
    Mol Microbiol; 1994 Oct; 14(2):207-16. PubMed ID: 7830567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular investigation of the role of ApxI and ApxII in the virulence of Actinobacillus pleuropneumoniae serotype 5.
    Reimer D; Frey J; Jansen R; Veit HP; Inzana TJ
    Microb Pathog; 1995 Mar; 18(3):197-209. PubMed ID: 7565014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knockout mutants of Actinobacillus pleuropneumoniae serotype 1 that are devoid of RTX toxins do not activate or kill porcine neutrophils.
    Jansen R; Briaire J; Smith HE; Dom P; Haesebrouck F; Kamp EM; Gielkens AL; Smits MA
    Infect Immun; 1995 Jan; 63(1):27-37. PubMed ID: 7806365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of the CAMP phenomenon in Actinobacillus pleuropneumoniae with the RTX toxins ApxI, ApxII and ApxIII.
    Frey J; Kuhn R; Nicolet J
    FEMS Microbiol Lett; 1994 Dec; 124(2):245-51. PubMed ID: 7813893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutation in the LPS outer core biosynthesis gene, galU, affects LPS interaction with the RTX toxins ApxI and ApxII and cytolytic activity of Actinobacillus pleuropneumoniae serotype 1.
    Ramjeet M; Cox AD; Hancock MA; Mourez M; Labrie J; Gottschalk M; Jacques M
    Mol Microbiol; 2008 Oct; 70(1):221-35. PubMed ID: 18713318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Both ApxI and ApxII of Actinobacillus pleuropneumoniae serotype 1 are necessary for full virulence.
    Boekema BK; Kamp EM; Smits MA; Smith HE; Stockhofe-Zurwieden N
    Vet Microbiol; 2004 May; 100(1-2):17-23. PubMed ID: 15135509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Actinobacillus pleuropneumoniae RTX-toxins: uniform designation of haemolysins, cytolysins, pleurotoxin and their genes.
    Frey J; Bosse JT; Chang YF; Cullen JM; Fenwick B; Gerlach GF; Gygi D; Haesebrouck F; Inzana TJ; Jansen R
    J Gen Microbiol; 1993 Aug; 139(8):1723-8. PubMed ID: 8409915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic map of the Actinobacillus pleuropneumoniae RTX-toxin (Apx) operons: characterization of the ApxIII operons.
    Jansen R; Briaire J; van Geel AB; Kamp EM; Gielkens AL; Smits MA
    Infect Immun; 1994 Oct; 62(10):4411-8. PubMed ID: 7927703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural analysis of the Actinobacillus pleuropneumoniae-RTX-toxin I (ApxI) operon.
    Jansen R; Briaire J; Kamp EM; Gielkens AL; Smits MA
    Infect Immun; 1993 Sep; 61(9):3688-95. PubMed ID: 8359891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RTX toxin genotypes and phenotypes in Actinobacillus pleuropneumoniae field strains.
    Beck M; van den Bosch JF; Jongenelen IM; Loeffen PL; Nielsen R; Nicolet J; Frey J
    J Clin Microbiol; 1994 Nov; 32(11):2749-54. PubMed ID: 7852567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the type I secretion system of the RTX toxin ApxII in "Actinobacillus porcitonsillarum".
    Kuhnert P; Schlatter Y; Frey J
    Vet Microbiol; 2005 May; 107(3-4):225-32. PubMed ID: 15863281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elucidating the role of ApxI in hemolysis and cellular damage by using a novel apxIA mutant of Actinobacillus pleuropneumoniae serotype 10.
    Chang NY; Chen ZW; Chen TH; Liao JW; Lin CC; Chien MS; Lee WC; Lin JH; Hsuan SL
    J Vet Sci; 2014; 15(1):81-9. PubMed ID: 23820218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. hlyIA-like sequence present in a genetic locus with low homology to appA in Actinobacillus pleuropneumoniae serotype 10.
    Nagai S; Takahashi K; Mitsui T; Yagihashi T
    J Vet Med Sci; 1993 Oct; 55(5):813-9. PubMed ID: 8286536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apx toxins in Pasteurellaceae species from animals.
    Schaller A; Kuhnert P; de la Puente-Redondo VA; Nicolet J; Frey J
    Vet Microbiol; 2000 Jun; 74(4):365-76. PubMed ID: 10831858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterisation of haemolytic RTX toxins produced by Australian isolates of Actinobacillus pleuropneumoniae.
    Tarigan S; Slocombe RF; Browning GF; Blackall PJ
    Aust Vet J; 1996 May; 73(5):164-9. PubMed ID: 8660237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production of Apx toxins by field strains of Actinobacillus pleuropneumoniae and Actinobacillus suis.
    Kamp EM; Vermeulen TM; Smits MA; Haagsma J
    Infect Immun; 1994 Sep; 62(9):4063-5. PubMed ID: 8063425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new variant of Actinobacillus pleuropneumoniae serotype 3 lacking the entire apxII operon.
    Kuhnert P; Rohde J; Korczak BM
    J Vet Diagn Invest; 2011 May; 23(3):556-9. PubMed ID: 21908290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth phase mediated regulation of the Actinobacillus pleuropneumoniae ApxI and ApxII toxins.
    Jarma E; Regassa LB
    Microb Pathog; 2004 Apr; 36(4):197-203. PubMed ID: 15001225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interference of outer membrane protein PalA with protective immunity against Actinobacillus pleuropneumoniae infections in vaccinated pigs.
    van den Bosch H; Frey J
    Vaccine; 2003 Sep; 21(25-26):3601-7. PubMed ID: 12922088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccination and protection of pigs against pleuropneumonia with a vaccine strain of Actinobacillus pleuropneumoniae produced by site-specific mutagenesis of the ApxII operon.
    Prideaux CT; Lenghaus C; Krywult J; Hodgson AL
    Infect Immun; 1999 Apr; 67(4):1962-6. PubMed ID: 10085043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.